Products 1013101-36-4

CAS 1013101-36-4 appears in our catalog under these names: PF-04691502/ 98.63% (existing batch purity), PF–04691502, PF-04691502 98+%, 2-Amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxy-3-pyridinyl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one, 98+%, 98+%, PF-04691502, 99.91%. Offered by: TargetMol, GLPBio, Ambeed, Chemat, MedChemExpress. Available pack sizes: 5mg, 10mg, 25mg, 50mg, 100mg, 10mM (in 1ml dmso), 1mg, 1 mg.

PF-04691502/ 98.63% (existing batch purity)
TargetMol
  • size: 5mg, 10mg, 25mg, 50mg
  • Variants: 5
from 432.54
View product
PF–04691502
GLPBio
  • size: 10mg, 5mg, 10mM (in 1ml dmso), 50mg
  • Variants: 4
from 667.25
View product
PF-04691502 98+%
Ambeed
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 5
from 197.94
View product
2-Amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxy-3-pyridinyl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one, 98+%, 98+%
Chemat
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 5
from 174.80
View product
PF-04691502, 99.91%
MedChemExpress
  • size: 1 mg, 100 mg, 50 mg, 10mM/1mL
  • Variants: 7
from 291.83
View product
Structural formula: {0} (CAS {1})

PF-04691502 is pI3K/mTOR Kinase Inhibitor PF-04691502 is an agent targeting the phosphatidylinositol 3 kinase (PI3K) and mammalian target of rapamycin (mTOR) in the PI3K/mTOR signaling pathway, with potential antineoplastic activity.

Source: ChEBI

Identity
Molecular formulaC22H27N5O4
Molecular weight425.5 g/mol
IUPAC name2-amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxy-3-pyridinyl)-4-methylpyrido[2,3-d]pyrimidin-7-one
InChIKeyXDLYKKIQACFMJG-UHFFFAOYSA-N
SMILESCC1=C2C=C(C(=O)N(C2=NC(=N1)N)C3CCC(CC3)OCCO)C4=CN=C(C=C4)OC

Computed by PubChem (NCBI)

Synonyms: Phenol Red, JIS s, 4tv3, orb1227154, orb1300936, XDLYKKIQACFMJG-IYBDPMFKSA-N, s2743
Isomers (same molecular formula)
2-(2,6-dioxopiperidin-3-yl)-5-(4-piperidin-4-ylpiperazin-1-yl)isoindole-1,3-dione C22H27N5O4
4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxybenzoic acid C22H27N5O4